Clarivate Plc (NYSE: CLVT)

Clarivate Plc is a public limited company incorporated on January 7 2019 under the laws of Jersey Channel Islands with its principal offices located at 70 St Mary Axe London EC3A 8BE United Kingdom and its shares traded on the New York Stock Exchange under the ticker CLVT. The company describes itself as a leading global provider of transformative intelligence that supports the entire innovation lifecycle from cultivating curiosity to protecting critical intellectual property assets. Clarivate Plc offers intelligence solutions workflow solutions and tech enabled services to customers in the Academia & Government Intellectual Property and Life Sciences & Healthcare end markets aiming to fuel the world's greatest breakthroughs by harnessing human ingenuity. As of December 31 2025 the company employed more than 12 000 people across over 40 countries. The company's vision is to fuel the world's greatest breakthroughs by harnessing human ingenuity and its mission is to advance the success of people and organizations through transformative intelligence and trusted partnership.

Clarivate Plc generates revenue primarily through subscription arrangements recurring contracts and transactional offerings. Subscription based revenues are derived from annual contracts that license the right to use its products or provide maintenance services delivering stable and predictable cash flows. Recurring revenues come from patent and trademark renewal services that customers engage on a regular basis to maintain intellectual property rights benefiting from the company's high annual renewal rates which exceed ninety percent. Transactional revenues are earned for specific deliverables such as content sales consulting engagements and software implementation services typically quoted on a product data set or project basis. The subscription model provides a reliable revenue base while transactional offerings allow flexibility for specific projects.

The company operates through the following segments: Academia & Government (A&G) Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). These segments are defined by the distinct products services and end markets they serve.

• Academia & Government (A&G) provides intelligence and workflow solutions for academic and government institutions including the Web of Science product family ProQuest content solutions and library software such as Alma Vega and Polaris to support the full research library lifecycle and research impact measurement using AI enabled tools. The segment also features the Academic AI platform which combines large language model technology with trusted scholarly content to deliver retrieval augmented generation and agentic AI capabilities for research and learning.

• Intellectual Property (IP) offers patent services patent intelligence brand IP solutions and IP management software including the Derwent World Patent Index Derwent Innovation CompuMark RiskMark IPfolio and FoundationIP to assist customers in protecting managing and commercializing patent and trademark assets. The segment provides patent maintenance administrative services trademark search and watch solutions and IP workflow automation tools such as IPfolio for portfolio management and FoundationIP for law firm services.

• Life Sciences & Healthcare (LS&H) delivers the Cortellis suite of products for research and development commercial and medtech needs including AI powered Regulatory Intelligence to help customers navigate drug development regulatory pathways market access and medical device commercialization. The segment also offers competitive intelligence clinical trial data and real world evidence analytics to support strategic decision making across the life sciences value chain.

Clarivate Plc believes it competes favorably on the depth breadth timeliness accuracy of its data and analysis the ease of use of its platforms and the value for price it offers. The company states that although it faces competition in specific markets and with respect to specific offerings it does not have a direct competitor across all of the markets it serves because of the breadth and depth of its portfolio. Clarivate Plc emphasizes that its competitive advantages stem from the richness of its curated data assets the integration of AI enabled technologies and its global reach across academia government intellectual property and life sciences sectors. The company has established an AI governance framework that sets principles for responsible development and deployment of generative AI across its product lines.

Clarivate Plc serves more than 45,000 customers worldwide spanning academic institutions and libraries research organizations corporations law firms government entities and companies in the pharmaceutical biotechnology and medical device sectors. Approximately 99 percent of the top 400 universities use its solutions more than 26,000 academic libraries benefit from its content over 40 patent offices rely on its data nine out of ten of the most valuable brands trust it with trademark needs over 1,600 corporations and law firms use its IP management software and it works with over 3,000 life sciences and healthcare customers. The company reports that its annual customer renewal rates exceed ninety percent reflecting strong satisfaction and loyalty across its diverse base. Its customer base is geographically diverse with significant presence in North America Europe Asia Pacific and other regions contributing to a balanced revenue stream.